NCT00286273View on ClinicalTrials.gov

Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration

PHASE4CompletedINTERVENTIONAL

Enrollment

215

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

January 31, 2008

Study Completion Date

March 31, 2008

Conditions

Kidney Failure, Acute

Interventions

DRUG

trisodium citrate

for regional anticoagulation of the extracorporeal CVVH circuit

DRUG

nadroparin

for anticoagulation of the extracorporeal CVVH circuit

Trial Locations (1)

1090HM

Onze Lieve Vrouwe Gasthuis, Amsterdam

All Listed Sponsors

lead

Onze Lieve Vrouwe Gasthuis

OTHER

NCT00286273 - Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration | Biotech Hunter | Biotech Hunter